P1.12. In Vivo Efficacy of AZD9592, an EGFR-cMET Bispecific ADC, in a Broad Panel of NSCLC Patient-Derived Xenograft Models - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Lara McGrath
Meta Tag
Speaker Lara McGrath
Topic Tumor Biology: Translational Biology - Translational Therapeutics
In Vivo Efficacy
EGFR-cMET Bispecific ADC
NSCLC Patient-Derived Xenograft Models
Molecular Mechanisms
Acquired Resistance
Tyrosine Kinase Inhibitors
Non-Small-Cell Lung Cancer
Preclinical Evaluation
Antibody-Drug Conjugate
Powered By